Cochlear has recently announced approval from the US Food and Drug Administration (FDA) for the Cochlear™ Nucleus® Profile™ Implant with Slim Straight Electrode (CI522). This new technology has been built with over 30 years of experience and developed though a close collaboration with some of the leading surgeons in the world. The Profile Series is set to be the thinnest cochlear implant platform in order to give an incredibly discreet appearance for both children and adults to be fitted with the implant.
“The Nucleus Profile Implant is built on the same reliability principles that are standard for all of our current and previous generation devices,” said Anthony Manna, President, Cochlear North America. “This approval further expands what is already the industry’s largest cochlear implant portfolio and supports a wider range of surgical techniques among implanting surgeons giving them and their patients the greatest possible choice.”
Cochlear has produced this new product by combining the industry’s thinnest full length electrode with a slim straight electrode. The product is designed to preserve as much of the cochlear as possible while delivering the best possible sound performance. This new product will also accommodate for individual preferences in their anatomy and cover an array of patient conditions. This product aims to contour to the head for a more discrete and streamline look and is roughly two times stronger other implants. The Nucleus Profile Implant has a smooth surface to reduce any risk of infection with a magnet that can be removed when conducting MRI scans.
“This is fantastic news because it means that more patients can enjoy the comfort and discreetness of the thin Profile Implant no matter which electrode is best for them,”
said Dr. Peter Weber, M.D., MBA, Otolaryngology, UMass Memorial Medical Center, and Medical Advisor to Cochlear. People who choose the Nucleus Profile with Slim Straight Electrode will also receive the market-leading Nucleus 6 Sound Processor, which delivers more smart features than ever before, including true 2.4 GHz wireless connectivity and SmartSound® iQ, a proprietary signal processing platform that automatically adapts to different acoustic environments. These features are not only intended to help make listening easier, they are designed to help users hear and understand speech in all listening situations, even in noise.”
Advances in cochlear technology help to make individuals with hearing impairments more easily accepted within the community as well as increase the ease at which these devices can be integrated into everyday life.